Genscript Biotech (HKSE:01548) Change In Inventory : HK$-31 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Genscript Biotech Change In Inventory?

Genscript Biotech's change in inventory for the quarter that ended in Dec. 2023 was HK$-37 Mil. It means Genscript Biotech's inventory increased by HK$37 Mil from Jun. 2023 to Dec. 2023 .

Genscript Biotech's change in inventory for the fiscal year that ended in Dec. 2023 was HK$-31 Mil. It means Genscript Biotech's inventory increased by HK$31 Mil from Dec. 2022 to Dec. 2023 .

Genscript Biotech's Total Inventories for the quarter that ended in Dec. 2023 was HK$417 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Genscript Biotech's Days Inventory for the quarter that ended in Dec. 2023 was 44.84.

Inventory Turnover measures how fast the company turns over its inventory within a year. Genscript Biotech's Inventory Turnover for the quarter that ended in Dec. 2023 was 4.07.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Genscript Biotech's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.12.

Genscript Biotech Change In Inventory Historical Data

The historical data trend for Genscript Biotech's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genscript Biotech Change In Inventory Chart

Genscript Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-65.70

-116.01

-118.04

-152.01

-30.68

Genscript Biotech Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial														-90.86	-111.40	-41.50	5.86	-36.52

Genscript Biotech Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-31 Mil.

Genscript Biotech (HKSE:01548) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Genscript Biotech's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	410.0695	/	1669.056	*	365 / 2
	=	44.84

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Genscript Biotech's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1669.056	/	410.0695
	=	4.07

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Genscript Biotech's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	410.0695	/	3500.493
	=	0.12

Genscript Biotech Change In Inventory Related Terms

Thank you for viewing the detailed overview of Genscript Biotech's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Genscript Biotech (HKSE:01548) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (HKSE:01548) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

GNNSF:USA G51:Germany

Address

No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, CHN, 211100

Website

https://www.genscript.com

GenScript Biotech is a China-based provider of life science research services and products. Founded in 2002, it is best known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, it owns 57.1% of Nasdaq-listed Legend Biotech, whose key pipeline asset is a BCMA-targeting CAR-T treatment for multiple myeloma. We estimate that more than two thirds of GenScript's valuation is from its ownership stake in Legend.

Executives

Wang Luquan	2401 A concert party to an agreement to buy shares
Wang Ye	2101 Beneficial owner
Zhang Fangliang	2401 A concert party to an agreement to buy shares
Huang Lili	2202 Interest of your spouse
Hu Zhiyong	2201 Interest of corporation controlled by you
Jin Weihong	2201 Interest of corporation controlled by you
Genscript Corporation	2101 Beneficial owner
Hillhouse Fund V, L.p.	2201 Interest of corporation controlled by you
Hillhouse Investment Management V, Ltd.	2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd.	2102 Investment manager
Gns Holdings Limited	2101 Beneficial owner
Hillhouse Capital Management V, Ltd.	2201 Interest of corporation controlled by you
Hillhouse Capital Management, Ltd.	2102 Investment manager

Genscript Biotech (HKSE:01548) Headlines

No Headlines